The rapidly growing field of tissue viability.


As we start a new decade and thoughts turn to the next stage of development for the rapidly growing field of tissue viability, two perennial issues remain to be fully resolved. The value of tissue viability services (including the role of the specialist tissue viability nurse) has not been clearly demonstrated either in terms of improved patient outcomes or reduced expenditure on wound prevention and treatment. Without such evidence continued services in these times of health service expenditure reductions cannot be guaranteed. Obtaining such evidence will not be easy given the widespread diffusion of dedicated wound healing services within most health care organisations! Let us hope that it is not too late to formally investigate the impact tissue viability services can have! The second issue that has never been satisfactorily resolved is the relationship between tissue viability services and the commercial organisations that supply the medical devices used in treatment and prevention. Over the past eighteen months there have been emerging guidance from associations such as the European Medical Technology Industry Association (Eucomed) to protect both manufacturer and health professional when working together. Such initiatives are to be warmly welcomed and full details of this code of conduct are available at aspx. In a recent clarification of this code of

DOI: 10.1016/j.jtv.2010.01.001

Cite this paper

@article{Clark2010TheRG, title={The rapidly growing field of tissue viability.}, author={Michael D Clark}, journal={Journal of tissue viability}, year={2010}, volume={19 1}, pages={1} }